Raiffeisen Bank International AG Has $36.20 Million Stock Position in Colgate-Palmolive Company $CL

Raiffeisen Bank International AG increased its stake in Colgate-Palmolive Company (NYSE:CL) by 3.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 450,234 shares of the company’s stock after buying an additional 14,762 shares during the quarter. Raiffeisen Bank International AG’s holdings in Colgate-Palmolive were worth $36,199,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in CL. ProShare Advisors LLC increased its stake in Colgate-Palmolive by 11.0% during the 3rd quarter. ProShare Advisors LLC now owns 2,047,542 shares of the company’s stock worth $163,681,000 after acquiring an additional 202,379 shares during the period. Providence Capital Advisors LLC acquired a new stake in shares of Colgate-Palmolive during the 3rd quarter worth $5,373,000. Asset Management One Co. Ltd. increased its position in shares of Colgate-Palmolive by 3.9% in the third quarter. Asset Management One Co. Ltd. now owns 422,292 shares of the company’s stock worth $33,758,000 after purchasing an additional 16,017 shares during the period. Vanguard Group Inc. raised its stake in Colgate-Palmolive by 1.2% in the second quarter. Vanguard Group Inc. now owns 82,751,689 shares of the company’s stock valued at $7,522,129,000 after purchasing an additional 993,432 shares in the last quarter. Finally, TD Waterhouse Canada Inc. lifted its position in Colgate-Palmolive by 248.5% during the third quarter. TD Waterhouse Canada Inc. now owns 87,410 shares of the company’s stock worth $6,909,000 after purchasing an additional 62,327 shares during the period. 80.41% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the stock. Royal Bank Of Canada upgraded shares of Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 target price for the company in a research report on Tuesday, December 9th. Barclays upped their price objective on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 3rd. Jefferies Financial Group raised their target price on shares of Colgate-Palmolive from $85.00 to $91.00 and gave the company a “hold” rating in a research report on Monday, February 2nd. Evercore upped their price target on shares of Colgate-Palmolive from $94.00 to $100.00 and gave the stock an “outperform” rating in a report on Monday, February 2nd. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Colgate-Palmolive in a report on Wednesday, January 21st. Eleven research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $94.75.

Colgate-Palmolive Price Performance

Shares of NYSE:CL opened at $95.07 on Friday. The company has a debt-to-equity ratio of 5.90, a quick ratio of 0.27 and a current ratio of 0.42. Colgate-Palmolive Company has a 52 week low of $74.54 and a 52 week high of $100.18. The firm has a market cap of $76.63 billion, a PE ratio of 36.29, a price-to-earnings-growth ratio of 4.24 and a beta of 0.29. The firm’s fifty day moving average is $85.61 and its 200-day moving average is $82.27.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, January 30th. The company reported $0.95 earnings per share for the quarter, beating analysts’ consensus estimates of $0.91 by $0.04. The business had revenue of $5.23 billion during the quarter, compared to the consensus estimate of $5.13 billion. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.Colgate-Palmolive’s quarterly revenue was up 5.8% on a year-over-year basis. During the same period in the prior year, the business posted $0.91 earnings per share. Sell-side analysts predict that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 13th. Investors of record on Wednesday, January 21st were paid a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend was Wednesday, January 21st. Colgate-Palmolive’s payout ratio is currently 79.39%.

Insider Buying and Selling

In other news, COO Panagiotis Tsourapas sold 15,000 shares of the stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $97.81, for a total transaction of $1,467,150.00. Following the completion of the sale, the chief operating officer directly owned 10,415 shares in the company, valued at $1,018,691.15. This represents a 59.02% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Sally Massey sold 15,851 shares of the business’s stock in a transaction on Thursday, February 5th. The shares were sold at an average price of $95.03, for a total transaction of $1,506,320.53. Following the completion of the transaction, the insider owned 13,751 shares in the company, valued at approximately $1,306,757.53. The trade was a 53.55% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 184,683 shares of company stock valued at $17,486,693. Insiders own 0.34% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.